Previous close | 0.9700 |
Open | 25.5000 |
Bid | 1.0400 |
Ask | 1.5700 |
Strike | 210.00 |
Expiry date | 2023-01-20 |
Day's range | 0.9700 - 0.9700 |
Contract range | N/A |
Volume | |
Open interest | 214 |
Agios Pharmaceuticals' (AGIO) posts encouraging results for the second quarter. The company is enrolling participants across five pivotal studies evaluating the lead drug Pyrukynd.
Nektar (NKTR) reports dismal second-quarter 2022 results. The company's operating expenses increased due to restructuring expenses of $106.0 million incurred during the quarter.
Novavax (NVAX) closed the most recent trading day at $61.93, moving +1.34% from the previous trading session.